Loading
CP
Celator Pharmaceuticals Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Morenstein Scott D, was filed 07 Dec 2015.
Celator Pharmaceuticals Inc: what insiders have been doing
Celator Pharmaceuticals Inc is a listed company. Its insiders report their share dealings to SEC (Form 4). Nothing new has been filed by managers of Celator Pharmaceuticals Inc in twelve months, the latest record being from 13 July 2016.
The full history, which starts in 2013, counts 14 purchases against no sales.
This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
68
Thresholds
n/a
Buy Volume
€152,211
14 ops. · all time
Sell Volume
n/a
n/a
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Last declaration on 13 July 2016
Declarations68 total
40,614 sharesCommon StockSEC:0001192482-16-000665:0
47,265 sharesCommon StockSEC:0001192482-16-000665:1
1,327,888 shares@ US$30.25Common StockSEC:0001192482-16-000665:2
637,962 shares@ US$30.25Common StockSEC:0001192482-16-000665:3
6,277 shares@ US$30.250.6% of flowCommon StockSEC:0000919574-16-014070:0
2,378,924 shares@ US$30.25Common StockSEC:0000904454-16-001317:0
16,733 shares@ US$30.25Common StockSEC:0000904454-16-001317:1
5,867 shares@ US$30.25Common StockSEC:0000904454-16-001317:2
1,591,750 shares@ US$30.2573.8% of flowCommon StockSEC:0000919574-16-014072:0
564,222 shares@ US$30.2526.2% of flowCommon StockSEC:0000919574-16-014072:1
1,039,109 shares@ US$30.2587.8% of flowCommon StockSEC:0000919574-16-014068:0
143,986 shares@ US$30.2512.2% of flowCommon StockSEC:0000919574-16-014068:1
20,000 shares@ US$30.25100.0% of flowCommon StockSEC:0000899243-16-024948:0
107,515 shares@ US$30.2585.5% of flowCommon StockSEC:0000899243-16-024952:0
7,468 shares@ US$30.255.9% of flowCommon StockSEC:0000899243-16-024952:1
3,631 shares@ US$30.252.9% of flowCommon StockSEC:0000899243-16-024952:2
301,518 shares@ US$30.2592.7% of flowCommon StockSEC:0000899243-16-024954:0
156,064 shares@ US$30.2592.7% of flowCommon StockSEC:0000899243-16-024958:0
●
Same trade as the filing by Valence Life Sciences GP II LLC, counted once
31M USD19SEC
1,039,109 shares@ US$30.2599.4% of flowCommon StockSEC:0000919574-16-014070:1
71,887 shares@ US$3.124.4% of flowCommon StockSEC:0000899243-16-024767:0
38,135 shares@ US$3.371.3% of flowCommon StockSEC:0000899243-16-024768:0
117,064 shares@ US$2.442.9% of flowCommon StockSEC:0000899243-16-024768:1
96,276 shares@ US$3.123.1% of flowCommon StockSEC:0000899243-16-024768:2
1,665 shares0Common StockSEC:0000899243-16-024118:0
56,875 shares@ US$1.321.4% of flowCommon StockSEC:0000899243-16-023719:0
25 of 68 declarations
About Celator Pharmaceuticals Inc
Celator Pharmaceuticals Inc is a biopharmaceutical company focused on developing treatments for cancer. It utilizes innovative technologies to enhance the efficacy of cancer drugs.
